IMAX Corporation (NYSE:IMAX) received a reiterated Buy rating and $35 price target from Rosenblatt, citing a blowout Q1 box office of $280 million, well above projections. The success of Ne Zha 2 drove $162.6M for IMAX. Despite China trade concerns, no official restrictions surfaced. The company remains well-positioned with strong local content, expanding partnerships, and a blockbuster-packed 2025–2026 film slate.
Latest Ratings for IMAX
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 2021 | Wells Fargo | Initiates Coverage On | Overweight | |
| Jun 2021 | Goldman Sachs | Downgrades | Neutral | Sell |
| Apr 2021 | Wedbush | Upgrades | Neutral | Outperform |
